Empowering cancer research in Europe: the EUCAIM cancer imaging infrastructure.

IF 4.1 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Luis Martí-Bonmatí, Ignacio Blanquer, Manolis Tsiknakis, Gianna Tsakou, Ricard Martinez, Salvador Capella-Gutierrez, Sara Zullino, Janos Meszaros, Esther E Bron, Jose Luis Gelpi, Katrine Riklund, Linda Chaabane, Heinz-Peter Schlemmer, Mario Aznar, Patricia Serrano Candelas, Peter Gordebeke, Monika Hierath
{"title":"Empowering cancer research in Europe: the EUCAIM cancer imaging infrastructure.","authors":"Luis Martí-Bonmatí, Ignacio Blanquer, Manolis Tsiknakis, Gianna Tsakou, Ricard Martinez, Salvador Capella-Gutierrez, Sara Zullino, Janos Meszaros, Esther E Bron, Jose Luis Gelpi, Katrine Riklund, Linda Chaabane, Heinz-Peter Schlemmer, Mario Aznar, Patricia Serrano Candelas, Peter Gordebeke, Monika Hierath","doi":"10.1186/s13244-025-01913-x","DOIUrl":null,"url":null,"abstract":"<p><p>Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe's Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EU-funded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data. The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate data-intensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing. CRITICAL RELEVANCE STATEMENT: EUCAIM's federated infrastructure for cancer image data advances medical research and related AI development in Europe. It addresses the current fragmentation and heterogeneity of data repositories is legally compliant, and facilitates collaboration among clinicians, researchers, and innovators. KEY POINTS: AI solutions to advance cancer care rely on large, high-quality real-world datasets. EUCAIM's federated infrastructure for cancer image data empowers cancer research in Europe. It provides access to research tools, images, and related clinical, pathology and molecular data.</p>","PeriodicalId":13639,"journal":{"name":"Insights into Imaging","volume":"16 1","pages":"47"},"PeriodicalIF":4.1000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11850660/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Insights into Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13244-025-01913-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe's Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EU-funded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data. The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate data-intensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing. CRITICAL RELEVANCE STATEMENT: EUCAIM's federated infrastructure for cancer image data advances medical research and related AI development in Europe. It addresses the current fragmentation and heterogeneity of data repositories is legally compliant, and facilitates collaboration among clinicians, researchers, and innovators. KEY POINTS: AI solutions to advance cancer care rely on large, high-quality real-world datasets. EUCAIM's federated infrastructure for cancer image data empowers cancer research in Europe. It provides access to research tools, images, and related clinical, pathology and molecular data.

增强欧洲癌症研究能力:EUCAIM癌症成像基础设施。
人工智能(AI)是一项强大的技术,有可能颠覆癌症的检测、诊断和治疗。然而,开发新的人工智能算法需要访问庞大而复杂的现实世界数据集。尽管这样的数据集不断生成,但由于数据在众多存储库和站点上的碎片化、异构性、缺乏注释和潜在的隐私问题,对它们的访问受到限制。欧洲癌症成像倡议是欧洲战胜癌症计划的旗舰项目,旨在通过欧盟资助的欧洲癌症图像联合会(EUCAIM)项目建立一个联合的欧洲癌症图像基础设施,为癌症患者、临床医生和研究人员释放人工智能的力量。这一基础设施被称为“欧洲癌症成像”,它建立在人工智能健康成像网络(AI4HI)、已建立的欧洲研究基础设施(欧洲生物成像、BBMRI-ERIC、EATRIS、ECRIN和ELIXIR)以及众多提供研究工具、图像以及相关临床、病理和分子数据的相关合作伙伴的基础上。该基础设施以临床医生、研究人员和创新者为目标,提供开发和验证基于数据密集型人工智能和其他支持精准医疗的it临床决策系统的方法。通用数据模型,包括链接超本体、质量标准、符合FAIR(可查找性、可访问性、互操作性和可重用性)原则、数据注释、管理和匿名化服务,以确保数据质量和互操作性、一致性和隐私性。2024年夏天,EUCAIM项目发布了欧盟范围内基础设施的第一个原型,其综合仪表板集成了数据集发现、联邦搜索、数据访问请求、元数据收集、注释、安全处理环境和联邦处理等应用程序。关键相关性声明:EUCAIM的癌症图像数据联合基础设施推动了欧洲的医学研究和相关人工智能开发。它解决了当前数据存储库的碎片化和异构性,符合法律要求,并促进了临床医生、研究人员和创新者之间的协作。重点:推进癌症治疗的人工智能解决方案依赖于大型、高质量的真实世界数据集。EUCAIM的联合癌症图像数据基础设施为欧洲的癌症研究提供了支持。它提供了对研究工具、图像和相关临床、病理和分子数据的访问。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Insights into Imaging
Insights into Imaging Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
7.30
自引率
4.30%
发文量
182
审稿时长
13 weeks
期刊介绍: Insights into Imaging (I³) is a peer-reviewed open access journal published under the brand SpringerOpen. All content published in the journal is freely available online to anyone, anywhere! I³ continuously updates scientific knowledge and progress in best-practice standards in radiology through the publication of original articles and state-of-the-art reviews and opinions, along with recommendations and statements from the leading radiological societies in Europe. Founded by the European Society of Radiology (ESR), I³ creates a platform for educational material, guidelines and recommendations, and a forum for topics of controversy. A balanced combination of review articles, original papers, short communications from European radiological congresses and information on society matters makes I³ an indispensable source for current information in this field. I³ is owned by the ESR, however authors retain copyright to their article according to the Creative Commons Attribution License (see Copyright and License Agreement). All articles can be read, redistributed and reused for free, as long as the author of the original work is cited properly. The open access fees (article-processing charges) for this journal are kindly sponsored by ESR for all Members. The journal went open access in 2012, which means that all articles published since then are freely available online.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信